Tuesday, March 12, 2024

🌎 Xylem Initiated, Coinbase Global Upgraded, ACADIA Pharmaceuticals Downgraded and more...

Ratings changes for Sorrento Therapeutics, SuperCom, Union Bankshares, Sirius XM, Cadence Design Systems, Moleculin Biotech, Bitdeer Technologies Group and more...Text "MarketBeat" to 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports. Learn More.
Unsubscribe.
MarketBeat Daily Ratings
March 12th, 2024
S and P pricesDow pricesQQQ prices
Follow MarketBeat on Twitter Join the MarketBeat Facebook Group Subscribe on YouTube 

Today's Top Stories
ON Holdings Stock Price Tumbles: Is Now The Time to Buy?
Reddit is preparing to sell shares to the public. Here's what you need to know
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Behind the Markets)
GameStop Stock Is Giving Investors a Familiar Feeling, But Why?
An alert Polish taxi driver averts a scam in which an elderly woman could have lost about $36,000
Oracle Drives Next Era of AI Advancement: Stock Skyrockets by 15%
Dark Clouds Roll in After Airliner Issues Dreary Forecast
His system isolated NVIDIA - Here's His Next Buy. (Chaikin Analytics)
Active Rebound: 2 Discrete Semiconductor Stocks Making Moves
Southwest plans to reduce capacity, reevaluate 2024 financial outlook on delivery delays from Boeing
Nike Stock Is Where You Can Find Growth Opportunity
US inflation up again in February in latest sign that price pressures remain elevated
Crypto's Next Bull Run: Expert Insights with Robert Ross
Quick Links

Your Watchlist (Manage Your Watchlist and Monitor Your Portfolio)

Analysts' Upgrades
  • Ameresco (NYSE:AMRC) was upgraded by analysts at BNP Paribas from a "neutral" rating to an "outperform" rating. They now have a $34.00 price target on the stock. This represents a 60.7% upside from the current price of $21.16.
  • AnaptysBio (NASDAQ:ANAB) was upgraded by analysts at Wedbush from a "neutral" rating to an "outperform" rating. They now have a $34.00 price target on the stock, up previously from $20.00. This represents a 36.4% upside from the current price of $24.93.
  • Coinbase Global (NASDAQ:COIN) was upgraded by analysts at Raymond James from an "underperform" rating to a "market perform" rating.The current price is $258.03.
  • Carvana (NYSE:CVNA) was upgraded by analysts at Jefferies Financial Group Inc. from an "underperform" rating to a "hold" rating. They now have a $85.00 price target on the stock, up previously from $30.00. This represents a 9.6% upside from the current price of $77.59.
  • Dollar General (NYSE:DG) was upgraded by analysts at JPMorgan Chase & Co. from an "underweight" rating to a "neutral" rating. They now have a $158.00 price target on the stock, up previously from $120.00. This represents a 1.9% downside from the current price of $160.98.
  • HashiCorp (NASDAQ:HCP) was upgraded by analysts at Scotiabank from a "sector perform" rating to a "sector outperform" rating. They now have a $31.00 price target on the stock. This represents a 15.2% upside from the current price of $26.92.
  • Aurora Mobile (NASDAQ:JG) was upgraded by analysts at Alliance Global Partners from a "neutral" rating to a "buy" rating. They now have a $7.00 price target on the stock. This represents a 118.8% upside from the current price of $3.20.
  • Southwest Airlines (NYSE:LUV) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating. They now have a $40.00 price target on the stock. This represents a 38.7% upside from the current price of $28.83.
  • National Health Investors (NYSE:NHI) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. They now have a $67.00 price target on the stock. This represents a 12.4% upside from the current price of $59.62.
  • Oracle (NYSE:ORCL) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.The current price is $126.38.
  • PAR Technology (NYSE:PAR) was upgraded by analysts at Sidoti from a "neutral" rating to a "buy" rating. They now have a $61.00 price target on the stock. This represents a 37.7% upside from the current price of $44.30.
  • Ventyx Biosciences (NASDAQ:VTYX) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $16.00 price target on the stock, up previously from $7.00. This represents a 84.8% upside from the current price of $8.66.
  • Ventyx Biosciences (NASDAQ:VTYX) was upgraded by analysts at Oppenheimer Holdings Inc. from a "market perform" rating to an "outperform" rating. They now have a $12.00 price target on the stock. This represents a 38.6% upside from the current price of $8.66.
  • NCR Voyix (NYSE:VYX) was upgraded by analysts at Northcoast Research from a "neutral" rating to a "buy" rating. They now have a $17.00 price target on the stock. This represents a 32.7% upside from the current price of $12.81.
  • View today's most recent analysts' upgrades at MarketBeat.com right arrow


Analysts' Downgrades
  • ACADIA Pharmaceuticals (NASDAQ:ACAD) was downgraded by analysts at Mizuho from a "buy" rating to a "neutral" rating. They now have a $25.00 price target on the stock, down previously from $39.00. This represents a 23.2% upside from the current price of $20.29.
  • Antero Midstream (NYSE:AM) was downgraded by analysts at Tudor, Pickering, Holt & Co. from a "buy" rating to a "hold" rating. They now have a $13.00 price target on the stock, up previously from $12.00. This represents a 4.4% downside from the current price of $13.60.
  • Compañía de Minas Buenaventura S.A.A. (NYSE:BVN) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating.The current price is $16.73.
  • NGM Biopharmaceuticals (NASDAQ:NGM) was downgraded by analysts at Raymond James from an "outperform" rating to a "market perform" rating.The current price is $1.53.
  • SilverCrest Metals (NYSEAMERICAN:SILV) was downgraded by analysts at Desjardins from a "buy" rating to a "hold" rating.The current price is $6.12.
  • Sonendo (NYSE:SONX) was downgraded by analysts at Stifel Nicolaus from a "buy" rating to a "hold" rating.The current price is $0.10.
  • Alpha Teknova (NASDAQ:TKNO) was downgraded by analysts at BTIG Research from a "buy" rating to a "neutral" rating.The current price is $2.99.
  • View today's most recent analysts' downgrades at MarketBeat.com right arrow


Analysts' New Coverage
  • Bitdeer Technologies Group (NASDAQ:BTDR) is now covered by analysts at B. Riley. They set a "buy" rating and a $9.00 price target on the stock. This represents a 42.9% upside from the current price of $6.30.
  • Central Garden & Pet (NASDAQ:CENT) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $52.00 price target on the stock. This represents a 24.7% upside from the current price of $41.69.
  • DexCom (NASDAQ:DXCM) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $165.00 price target on the stock. This represents a 22.7% upside from the current price of $134.44.
  • Ingersoll Rand (NYSE:IR) is now covered by analysts at BNP Paribas. They set a "neutral" rating and a $92.00 price target on the stock. This represents a 2.3% upside from the current price of $89.97.
  • New York Times (NYSE:NYT) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $52.00 price target on the stock. This represents a 17.5% upside from the current price of $44.27.
  • Pentair (NYSE:PNR) is now covered by analysts at BNP Paribas. They set a "neutral" rating and a $86.00 price target on the stock. This represents a 4.8% upside from the current price of $82.03.
  • Regeneron Pharmaceuticals (NASDAQ:REGN) is now covered by analysts at Sanford C. Bernstein. They set an "outperform" rating and a $1,125.00 price target on the stock. This represents a 15.5% upside from the current price of $974.27.
  • BBB Foods (NYSE:TBBB) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $33.00 price target on the stock. This represents a 54.9% upside from the current price of $21.31.
  • Veralto (NYSE:VLTO) is now covered by analysts at BNP Paribas. They set an "outperform" rating and a $103.00 price target on the stock. This represents a 15.8% upside from the current price of $88.93.
  • Xylem (NYSE:XYL) is now covered by analysts at BNP Paribas. They set an "outperform" rating and a $150.00 price target on the stock. This represents a 17.7% upside from the current price of $127.44.
  • Zevra Therapeutics (NASDAQ:ZVRA) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.The current price is $6.29.
  • Zurn Elkay Water Solutions (NYSE:ZWS) is now covered by analysts at BNP Paribas. They set an "outperform" rating and a $40.00 price target on the stock. This represents a 26.4% upside from the current price of $31.65.
  • View today's most recent analysts' new coverage at MarketBeat.com right arrow

Upgrade Your Subscription
Manage Your Watchlist
Join Our Facebook Group

Thank you for subscribing to MarketBeat!
We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.
 
If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.
 
© 2006-2024 MarketBeat Media, LLC.
345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States.
 
Today's Bonus Content: One company did the impossible with AI
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Most important medical advance in 100 years

Artificial Intelligence is being harnessed to create breakthrough drugs no one has ever seen before. ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ...